The future is now, just unevenly distributed. So, instead of looking for Moon Shot "never been done before" blockbusters in 2019, like the cure for cancer, obesity, diabetes or Alzheimer's disease, perhaps it is more reasonable to take advantage of opportunities that already exist but that have not diffused into the practice of medicine nor have become the standard of care.
Opportunities will occur in 6 basic categories: drugs, device, digital health, care deliver models, policy/ecosystems and workforce pipeline :
What is your innovation strategy? How do you do innovation and will you need to change in 2019?
2019, like years past, will see significant advances in drugs, devices, digital health and care delivery. Physician entrepreneurs will see them and take advantage of the opportunities. Most doctors won't, so now is a good time to file this and paste it into your 2020 predictions blog. I don't think standing desks, open working spaces and hospital innovation centers will make the list.
Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs and Twitter@ArlenMD.
Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.